woogeeb
commented on
$SIA (C6L.SG)$ anyone know when we r receiving the august dividend payout @ 0.38?
1
2
woogeeb
liked and commented on
woogeeb
voted
Nvidia's stock has experienced a significant increase in value. It has seen impressive growth over the course of 2023, rising more than 160%. While some analysts believe there is still potential for further growth, Cathie Wood has expressed concerns about the current pricing, stating that Nvidia is priced "ahead of the curve."
In light of these differing opinions, do you think it is a good time to buy Nvidia or not?
$NVIDIA (NVDA.US)$ $Microsoft (MSFT.US)$ $Alphabet-C (GOOG.US)$ $Alphabet-A (GOOGL.US)$
In light of these differing opinions, do you think it is a good time to buy Nvidia or not?
$NVIDIA (NVDA.US)$ $Microsoft (MSFT.US)$ $Alphabet-C (GOOG.US)$ $Alphabet-A (GOOGL.US)$
4
woogeeb
voted
Rewards
● An equal share of 1,000 points: For mooers who correctly guess NVDA's closing price range on 25 May ET by 2:30 PM, May 25 ET. (e.g., If 50 mooers make a correct guess, each of them will get 20 points.)
● Exclusive 300 points: For the writer of the top post on analyzing NVDA's earnings preview as an inspiration reward.
*The selection is based on post quality, originality, and user engagement.
Note: 1. Rewards ...
● An equal share of 1,000 points: For mooers who correctly guess NVDA's closing price range on 25 May ET by 2:30 PM, May 25 ET. (e.g., If 50 mooers make a correct guess, each of them will get 20 points.)
● Exclusive 300 points: For the writer of the top post on analyzing NVDA's earnings preview as an inspiration reward.
*The selection is based on post quality, originality, and user engagement.
Note: 1. Rewards ...
39
52
$Pfizer (PFE.US)$
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.
1
woogeeb
commented on
woogeeb
liked
$SIA (C6L.SG)$ finally my holding for few months at 5.49 has break even hahhaa
4
woogeeb OP ping429 : Ah yea 21 just found it, thansk